arrow
K

Krzysztof Kałwak

Wroclaw Medical University
H指数:35
被引数:5,409

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment Outcomes and Prognostic Factors in Children with Myeloid Leukemia Associated with Down Syndrome: A Nationwide Polish Retrospective Study

唐氏综合征相关髓系白血病患儿的疗效及预后因素:一项全国性波兰回顾性研究

2026-09-290
OA
Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta

神经母细胞瘤患者在接受替莫唑胺、伊立替康和地努珠单抗β化疗免疫治疗后,自体干细胞移植治疗的静脉闭塞病发生率

Cancers
IF4.4
2026-09-090
OA
Clinical Analysis of Serratia Species Infections in Children and Adolescents Treated for Cancer or Undergoing Hematopoietic Stem Cell Transplantation—A Multicenter Nationwide Study

儿童和青少年中沙雷菌属感染的临床分析——一项多中心全国性研究

2026-09-080
OA
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Leukemia
IF13.4
2026-08-310
OA
Total body irradiation versus chemotherapy before stem cell transplantation in children aged two to four with acute lymphoblastic leukemia—an EBMT pediatric diseases working party study

儿童急性淋巴细胞白血病2至4岁患者造血干细胞移植前全身照射与化疗的比较——EBMT儿科疾病工作组研究

Leukemia
IF13.4
2026-08-210
OA
Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT

粪菌移植在急性移植物抗宿主病治疗中的应用:EBMT并发症工作组与儿科疾病工作组开展的一项回顾性研究

2026-08-180
PRE
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?

成人EBMT风险评分对于儿童急性白血病的造血干细胞移植是否有效和适用?

2026-07-200
OA
HLA-B*15:01 and HLA-DRB1*07:01 as novel markers of acute GVHD in pediatric HSCT

HLA-B*15:01和HLA-DRB1*07:01作为儿童HSCT中急性GVHD的新型标志物

2026-07-150
PRE
Characteristics and Outcomes of Adolescents (15–18 Years) with Chronic Myelogenous Leukemia (CML) in Chronic Phase: The Experience of the International Registry of Childhood CML

慢性粒细胞白血病慢性期青少年(15–18岁)的特征与结局:国际儿童CML登记研究的经验

Cancers
IF4.4
2026-06-170
OA
Access to CAR-T cell therapy in Central and Eastern Europe: persistent barriers and inequalities as of October/November 2025

中东欧地区CAR-T细胞疗法的可及性:截至2025年10/11月的持续障碍与不平等

2026-06-020
PRE
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

2024年EBMT活动报告:完成一百万例HCT和2万例CAR-T。细胞疗法的重要里程碑

2026-05-270
OAAI
The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT

儿童急性髓系白血病异基因造血细胞移植中移植前髓外疾病对预后的影响——代表PDWP/EBMT

2026-05-190
PRE
Single-cell profiling of CD19-directed CAR T-cell phenotypes and immune system dynamics in pediatric B-cell acute lymphoblastic leukemia

单细胞分析CD19靶向CAR T细胞表型及儿童B细胞急性淋巴细胞白血病的免疫系统动态

2026-05-010
OA
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)

544例t(6;9)/DEK::NUP214急性髓系白血病患者行异基因干细胞移植的结局:欧洲血液和骨髓移植组急性白血病工作组(ALWP)和儿科疾病工作组(PDWP)的代表性研究

2026-04-220
PRE
Enterococcal bacteremia in children with malignancy or after hematopoietic stem cell transplantation: real-world multicenter data from a nationwide survey in Poland (2014–2021)

儿童恶性肿瘤或造血干细胞移植后肠球菌败血症:来自波兰全国调查(2014–2021年)的真实世界多中心数据

2026-04-080
PRE
An extraction pipeline for analysis of hematopoietic stem cell transplantation data

一种用于分析造血干细胞移植数据的提取流程

2026-03-100
PRE
Outcome of Second Conditioned Allogeneic Stem Cell Transplant in Children with Non-SCID Inborn Errors of Immunity

非SCID原发性免疫缺陷病患儿接受第二次异基因造血干细胞移植的结局

2026-03-050
OAAI